700 results on '"Chiaramonte, M"'
Search Results
2. Stochastic inverse modeling and global sensitivity analysis to assist interpretation of drilling mud losses in fractured formations
3. Antibodies to Hepatitis A Virus in Italian Patients with Chronic Liver Disease
4. HBV and HCV Infection among Non-European Union Immigrants in North-East Italy
5. Probabilistic assessment of equivalent fracture aperture constrained on quasi-real-time drilling mud loss data
6. FRESHWATER CYANOBACTERIA, IDENTIFIED BY MICROSCOPIC AND MOLECULAR INVESTIGATIONS ON A COLONIZED FOUNTAIN SURFACE: A CASE STUDY IN PALERMO (SICILY, ITALY)
7. Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma
8. Localization of hepatitis C virus antigen(s) by immunohistochemistry on fixed-embedded liver tissue
9. Prevalence of Cytomegalovirus Infection in Italy
10. Hepatitis B Virus Infection in Prisons. A Seroepidemiological Survey in Prisoners and Attending Staff
11. Are Homes for the Elderly Still a Risk Area for HBV Infection?
12. Hepatitis C Virus Infection in Homosexual Men: A Seroepidemiological Study in Gay Clubs in North-East Italy
13. Seroepidemiology of Pertussis Infection in An Urban Childhood Population in Cameroon
14. Antibody Pattern of HCV Infection and Hepatocellular Carcinoma in Italy: A Case Control Study
15. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR
16. Early acid perception in NERD
17. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma
18. Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life
19. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
20. Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection
21. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy
22. Is hepatitis C virus a risk factor for thyroid autoimmunity?
23. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease
24. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres
25. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma
26. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance
27. Baseline seroepidemiology of hepatitis a virus infection among children and teenagers in Italy
28. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis
29. DAILY INTERFERON MONOTHERAPY VERSUS DAILY INTERFERON PLUS AMANTADINE IN THE TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS: SHORT-TERM RESPONSE
30. Primary sclerosing cholangitis (PSC): clinical, laboratory and survival analysis in children and adults
31. ASYMPTOMATIC HCV CARRIERS: ARE INFECTION RISK FACTORS, HCV GENOTYPES, DEMOGRAPHIC CHARACTERISTICS, OTHER HEPATOTOXIC AGENTS AFFECTING THE CLINICAL OUTCOME?
32. Colchicine in chronic hepatitis B: a pilot study
33. Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring
34. Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma
35. Localization of hepatitis C virus antigen(s) by immunohistochemistry on fixed-embedded liver tissue
36. P4.30: Endothelial Dysfunction and Cardiovascular Risk Profile in Patients with Chronic Hepatitis C Virus Infection
37. Hepatitis G virus infection
38. A history of tuberculosis infection
39. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
40. Risk management of HBsAg or anti-HCV positive healthcare workers in hospital
41. Multiple-Link Blockchain
42. Distributed Key Secret for Rewritable Blockchain
43. Significance of Platelet and AFP Levels and Liver Function Parameters for HCC Size and Survival
44. Prognosis of untreated hepatocellular carcinoma
45. Response to HBV vaccine in relation to anti-HCV and anti-HBc positivity: a study in intravenous drug addicts
46. Identification of a gene for chronic hepatitis B virus infection by genome-wide linkage analysis family-based association studies
47. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
48. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study
49. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
50. Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.